The Science Behind the Problem
Nitrosamines can form during drug production or even while medications are stored. Factors such as heat, humidity, or chemical interactions during manufacturing can contribute to their development.
Regulatory agencies like the FDA set strict limits on acceptable levels of these compounds. When testing reveals amounts above those thresholds, a recall is issued.
Importantly, short-term exposure is not considered dangerous. Cancer risk is generally associated with long-term accumulation over years. However, because millions of people take blood pressure medications daily, even small contamination risks are treated seriously and addressed immediately.
